BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 17538807)

  • 1. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacalcitol ointment for the treatment of nail psoriasis.
    Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
    J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
    Ricceri F; Pescitelli L; Tripo L; Bassi A; Prignano F
    Dermatol Ther; 2013; 26(1):77-8. PubMed ID: 23384024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
    Zakeri M; Valikhani M; Mortazavi H; Barzegari M
    Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H; Oz A; Turan H
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumaric acid esters in the management of severe psoriasis.
    Brewer L; Rogers S
    Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instability of topical ciclosporin emulsion for nail psoriasis.
    Prins AM; Vos K; Franssen EJ
    Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
    Lee JY
    Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Crowley JJ; Weinberg JM; Wu JJ; Robertson AD; Van Voorhees AS;
    JAMA Dermatol; 2015 Jan; 151(1):87-94. PubMed ID: 25471223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S; Lewis Jones S; Dawe R; Foerster J
    Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated granuloma annulare--treatment with fumaric acid esters.
    Eberlein-König B; Mempel M; Stahlecker J; Forer I; Ring J; Abeck D
    Dermatology; 2005; 210(3):223-6. PubMed ID: 15785051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumaric acid esters for severe psoriasis: the Leicestershire experience.
    Sladden MJ; Osborne JE; Hutchinson PE
    Br J Dermatol; 2006 Oct; 155(4):843-4. PubMed ID: 16965442
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B; Schneider I
    Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris].
    Mrowietz U; Rostami-Yazdi M; Neureither M; Reich K
    J Dtsch Dermatol Ges; 2009 Apr; 7 Suppl 2():S3-16. PubMed ID: 19522921
    [No Abstract]   [Full Text] [Related]  

  • 20. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care.
    Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M
    Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.